Del Mar, CA, United States of America

Stephanie De Los Rios

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2014-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Stephanie De Los Rios

Introduction

Stephanie De Los Rios is a prominent inventor based in Del Mar, California. She has made significant contributions to the field of biotechnology, particularly in the development of chimeric therapeutics. With a total of 2 patents to her name, her work is paving the way for advancements in therapeutic methods.

Latest Patents

Stephanie's latest patents include innovative approaches to chimeric therapeutics. One patent focuses on chimeric therapeutics, compositions, and methods for using them. This invention discloses modified viral core proteins that include mutations or modifications in immunogenic epitopes, which can be associated with therapeutic agents such as nucleic acids, proteins, or small molecules. Another patent outlines methods and compositions for controlling the assembly of viral proteins. This invention provides methods for controlling the assembly of modified viral core proteins into structures like viral capsids or nanocages, allowing for precise control over the assembly process.

Career Highlights

Stephanie De Los Rios is currently employed at Biomed Realty, L.P., where she continues to innovate in her field. Her work is characterized by a commitment to advancing therapeutic technologies that can have a profound impact on healthcare.

Collaborations

Some of her notable coworkers include Miguel De Los Rios and Jacek Ostrowski, who contribute to the collaborative environment that fosters innovation at Biomed Realty.

Conclusion

Stephanie De Los Rios exemplifies the spirit of innovation in biotechnology through her patents and contributions to therapeutic methods. Her work not only enhances our understanding of viral proteins but also opens new avenues for treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…